Standards Development in Action
As a coordinating body, SCB helps streamline the standards advancement process by driving momentum, aligning stakeholder efforts, and helping projects overcome obstacles.
The case studies featured below demonstrate how organizations are advancing standards to benefit the broad regenerative medicine community.
Vineti is working with SCB and industry stakeholders to address challenges surrounding autologous cell and tissue therapy labeling with more robust and specific standards.
Pluristyx initiated a standard development effort with support from SCB to help develop a set of common cryopreservation best practices for the regenerative medicine community.
ISBiotech helped lead a working group of more than 30 experts to rapidly develop a viral gene vector reference material for Human Adenovirus 5 (Ad5).